Cargando…
Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640100/ https://www.ncbi.nlm.nih.gov/pubmed/29226919 http://dx.doi.org/10.1136/esmoopen-2017-000272 |
| _version_ | 1783270990415921152 |
|---|---|
| author | Oosting, Sjoukje F Fehrmann, Rudolf S de Vries, Elisabeth G E |
| author_facet | Oosting, Sjoukje F Fehrmann, Rudolf S de Vries, Elisabeth G E |
| author_sort | Oosting, Sjoukje F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5640100 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56401002017-12-08 Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape Oosting, Sjoukje F Fehrmann, Rudolf S de Vries, Elisabeth G E ESMO Open Editorial BMJ Publishing Group 2017-10-09 /pmc/articles/PMC5640100/ /pubmed/29226919 http://dx.doi.org/10.1136/esmoopen-2017-000272 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Oosting, Sjoukje F Fehrmann, Rudolf S de Vries, Elisabeth G E Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title | Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title_full | Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title_fullStr | Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title_full_unstemmed | Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title_short | Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| title_sort | indispensable benefit of independent investigator-driven research in a changing clinical trial landscape |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640100/ https://www.ncbi.nlm.nih.gov/pubmed/29226919 http://dx.doi.org/10.1136/esmoopen-2017-000272 |
| work_keys_str_mv | AT oostingsjoukjef indispensablebenefitofindependentinvestigatordrivenresearchinachangingclinicaltriallandscape AT fehrmannrudolfs indispensablebenefitofindependentinvestigatordrivenresearchinachangingclinicaltriallandscape AT devrieselisabethge indispensablebenefitofindependentinvestigatordrivenresearchinachangingclinicaltriallandscape |